MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest Issue
A conversation with Sharrolyn Josse, worldwide president of VELYS Digital Surgery & Capital at DePuy Synthes. Contributed by Johnson & Johnson’s DePuy Synthes division with an introduction by Mary Stuart.
With a platform based on a proprietary, nondegradable biomimetic material, CorNeat Vision has the opportunity to treat many diseases. It begins where the need is greatest, by providing an artificial cornea to patients for whom corneal transplantation has failed or is contraindicated.
Massachusetts General Brigham Health System is building one of the most comprehensive longitudinal MSK databases in surgery, which it is using to develop predictive analytics and clinical support tools that can help providers make more effective clinical decisions. The multiyear effort is perhaps the most advanced of its kind and indicative of resources and timelines needed for high-quality computational approaches to improving patient care.